Institutional investors purchased a net $324.4 thousand shares of ILMN during the quarter ended December 2017 and now own 93.87% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JACKSON SQUARE PARTNERS LLC Bought 749.5 Thousand shares of Illumina Inc
ROBERT W. BAIRD & CO., INC. (EQU... Bought 595.6 Thousand shares of Illumina Inc
AGF INVESTMENTS, INC. Bought 364.2 Thousand shares of Illumina Inc